Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Payables (2017 - 2026)

AdaptHealth has reported Payables over the past 9 years, most recently at $553.7 million for Q4 2025.

  • For Q4 2025, Payables rose 26.42% year-over-year to $553.7 million; the TTM value through Dec 2025 reached $553.7 million, up 26.42%, while the annual FY2025 figure was $553.7 million, 26.42% up from the prior year.
  • Payables for Q4 2025 was $553.7 million at AdaptHealth, up from $521.7 million in the prior quarter.
  • Over five years, Payables peaked at $553.7 million in Q4 2025 and troughed at $48.3 million in Q3 2022.
  • A 5-year average of $331.9 million and a median of $354.5 million in 2021 define the central range for Payables.
  • Biggest five-year swings in Payables: soared 1678.47% in 2021 and later tumbled 83.22% in 2022.
  • Year by year, Payables stood at $358.4 million in 2021, then decreased by 5.83% to $337.5 million in 2022, then increased by 16.15% to $392.0 million in 2023, then rose by 11.73% to $438.0 million in 2024, then grew by 26.42% to $553.7 million in 2025.
  • Business Quant data shows Payables for AHCO at $553.7 million in Q4 2025, $521.7 million in Q3 2025, and $477.2 million in Q2 2025.